Arteris is trading at $19.60, down 6.35%, with broader market and semiconductor sentiment the likely pressure.
- It was reported down 5.4% in pre-market trading amid semiconductor-sector weakness, with no company-specific catalyst identified.
- Technology-share weakness and concerns after Lam Research flagged supply constraints delaying shipments and a lower China revenue contribution added to market pressure.
- Arteris will report third-quarter results on November 5, 2026; that upcoming date does not explain the October 22 decline.